Association between diabetes at different diagnostic ages and risk of cancer incidence and mortality: a cohort study

被引:2
|
作者
Peng, Yu [1 ]
Liu, Fubin [1 ]
Wang, Peng [1 ]
Qiao, Yating [1 ]
Si, Changyu [1 ]
Wang, Xixuan [1 ]
Gong, Jianxiao [1 ]
Zhou, Huijun [1 ]
Song, Fengju [1 ]
Song, Fangfang [1 ]
机构
[1] Tianjin Med Univ, Key Lab Prevent & Control Major Dis Populat, Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc,Minist Educ,Dept Epidemiol, Tianjin, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
diabetes; age at diagnosis; cancer incidence; cancer mortality; UK Biobank; TYPE-2; EPIDEMIOLOGY;
D O I
10.3389/fendo.2023.1277935
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Different ages for diagnosis of diabetes have diverse effects on risks of cardiovascular disease, dementia, and mortality, but there is little evidence of cancer. This study investigated the relationship between diabetes at different diagnostic ages and risks of cancer incidence and mortality in people aged 37-73 years.Methods: Participants with diabetes in the UK Biobank prospective cohort were divided into four groups: <= 40, 41-50, 51-60, and >60 years according to age at diagnosis. A total of 26,318 diabetics and 105,272 controls (1:4 randomly selected for each diabetic matched by the same baseline age) were included. We calculated the incidence density, standardized incidence, and mortality rates of cancer. Cox proportional hazard model was used to examine the associations of diabetes at different diagnostic ages with cancer incidence and mortality, followed by subgroup analyses.Results: Compared to corresponding controls, standardized incidence and mortality rates of overall and digestive system cancers were higher in diabetes diagnosed at age 41-50, 51-60, and >60 years, especially at 51-60 years. Individuals diagnosed with diabetes at different ages were at higher risk to develop site-specific cancers, with a prominently increased risk of liver cancer since the diagnosis age of >40 years. Significantly, participants with diabetes diagnosed at 51-60 years were correlated with various site-specific cancer risks [hazard ratio (HR) for incidence: 1.088-2.416, HR for mortality: 1.276-3.269]. Moreover, for mortality of digestive system cancers, we observed an interaction effect between smoking and diabetes diagnosed at 51-60 years.Conclusion: Our findings highlighted that the age at diagnosis of diabetes, especially 51-60 years, was critical risks of cancer incidence and mortality and may represent a potential preventative window for cancer.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] The association between diabetes and cancer incidence and mortality in the NIH-AARP study
    Lai, Gabriel
    Park, Yikyung
    Hartge, Patricia
    Hollenbeck, Albert
    Schatzkin, Arthur
    Freedman, Neal
    CANCER RESEARCH, 2011, 71
  • [2] Association between family history with lung cancer incidence and mortality risk in the Asia Cohort Consortium
    Kishida, Rie
    Yin, Xin
    Abe, Sarah Krull
    Rahman, Md. Shafiur
    Saito, Eiko
    Islam, Md. Rashedul
    Lan, Qing
    Blechter, Batel
    Rothman, Nathaniel
    Sawada, Norie
    Tamakoshi, Akiko
    Shu, Xiao-Ou
    Hozawa, Atsushi
    Kanemura, Seiki
    Kim, Jeongseon
    Sugawara, Yumi
    Park, Sue K.
    Kweon, Sun-Seog
    Ahsan, Habibul
    Boffetta, Paolo
    Chia, Kee Seng
    Matsuo, Keitaro
    Qiao, You-Lin
    Zheng, Wei
    Inoue, Manami
    Kang, Daehee
    Seow, Wei Jie
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (04) : 723 - 733
  • [3] Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes
    Okada, Sadanori
    Morimoto, Takeshi
    Ogawa, Hisao
    Soejima, Hirofumi
    Matsumoto, Chisa
    Sakuma, Mio
    Nakayama, Masafumi
    Doi, Naofumi
    Jinnouchi, Hideaki
    Waki, Masako
    Masuda, Izuru
    Saito, Yoshihiko
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (03) : 632 - 639
  • [4] Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes
    Sadanori Okada
    Takeshi Morimoto
    Hisao Ogawa
    Hirofumi Soejima
    Chisa Matsumoto
    Mio Sakuma
    Masafumi Nakayama
    Naofumi Doi
    Hideaki Jinnouchi
    Masako Waki
    Izuru Masuda
    Yoshihiko Saito
    Journal of General Internal Medicine, 2021, 36 : 632 - 639
  • [5] Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes
    Orchard, Suzanne G.
    Lockery, Jessica E.
    Broder, Jonathan C.
    Ernst, Michael E.
    Espinoza, Sara
    Gibbs, Peter
    Wolfe, Rory
    Polekhina, Galina
    Zoungas, Sophia
    Loomans-Kropp, Holli A.
    Woods, Robyn L.
    ASPREE Investigator Grp
    JNCI CANCER SPECTRUM, 2023, 7 (02)
  • [6] Multivitamin use and the risk of mortality and cancer incidence in the Multiethnic Cohort Study
    Park, Song-Yi
    Murphy, Suzanne P.
    Wilkens, Lynne R.
    Henderson, Brian E.
    Kolonel, Laurence N.
    FASEB JOURNAL, 2011, 25
  • [7] Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study
    Deng, Zixuan
    Gu, Yunjuan
    Hou, Xuhong
    Zhang, Lei
    Bao, Yuqian
    Hu, Cheng
    Jia, Weiping
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (03) : 325 - 332
  • [8] ASSOCIATION BETWEEN PHYSICAL ACTIVITY AND INCIDENCE OF COLORECTAL CANCER IN PATIENTS WITH DIABETES MELLITUS: A NATIONWIDE COHORT STUDY
    Lee, Su Young
    Cheung, Dae Young
    Il Kim, Jin
    GASTROENTEROLOGY, 2024, 166 (05) : S358 - S358
  • [9] Interethnic Differences in Bladder Cancer Incidence and the Association between Type 2 Diabetes and Bladder Cancer in the Multiethnic Cohort Study
    Bogumil, David
    Cortessis, Victoria K.
    Wilkens, Lynne R.
    Le Marchand, Loic
    Haiman, Christopher A.
    Maskarinec, Gertraud
    Setiawan, Veronica Wendy
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (05): : 755 - 762
  • [10] Association between adherence to Eat-Lancet diet and incidence and mortality of lung cancer: A prospective cohort study
    Xiao, Yi
    Peng, Linglong
    Xu, Zhiquan
    Tang, Yunhao
    He, Hongmei
    Gu, Haitao
    Wang, Yaxu
    Xiang, Ling
    CANCER SCIENCE, 2023, 114 (11) : 4433 - 4444